Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 55 out of 100. Disease mechanisms

Topic: Brain proteins, microglia and lab models

ABSTRACT Positron Emission Tomography (PET) of tau is considered “the” indicator of Alzheimer's pathology. However, non‐PET proxies would be helpful for wider accessibility. We used Neurite Orientation Dispersion and Density Imaging (NODDI)‐derived indices (i.e., orientation dispersion [ODI], neurite density [NDI], and free‐water [fISO]) to determine relationships of gray matter microstructure with tau and cognitive impairment. We assessed the fit between NODDI indices, cortical thickness/subcortical volume (CT/ScVol), and tau via multiple factor analysis (MFA) using data from 80 participants from the ADNI‐3 dataset with overlapping multishell diffusion‐weighted and tau‐PET scans ([ 18 F]AV‐1451); 49 were considered cognitively normal older adults (age ~74 years), 26 were diagnosed with mild cognitive impairment (age ~75 years), and five had Alzheimer's dementia (age ~78 years). fISO and tau shared a large amount of spatial overlap, and both strongly correlated with the first MFA dimension. Macrostructural features (i.e., CT/ScVol) were 7% less related to this first MFA dimension than fISO and 8% less than tau. Subsequent mediation analyses demonstrated that fISO mediated the relationship between CT/ScVol and tau, explaining all of the variance. Our results suggest that microstructural features derived from NODDI such as fISO might be useful adjunct markers to tau, which needs to be confirmed in longitudinal studies. Cortical fISO, rather than macrostructure (i.e., CT/ScVol), may represent tau's impact on the brain (and, by extension, cognition). image

Key findings

Why it matters

In 80 participants from the ADNI-3 dataset, a diffusion imaging measure called free-water mediated the relationship between cortical thickness/subcortical volume and tau. The authors suggest this measure might be a useful adjunct marker to tau, but say it needs confirmation in longitudinal studies.

Study details

How this study scored 55/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 1 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 2 of 7; Citations per year 1 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record left out, no data; Institution's track record 2 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 53 of the 96 points it could be judged on, which is 55 of 100. Total 55 of 100.53 of the 96 points we could judge = 55 of 100

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 53 of the 96 points we could judge it on, which is 55 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Journal of Neurochemistry)
Journal's citation record 3 / 4 Journal of Neurochemistry: journal h-index 349 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 1 / 4 80 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 7 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 2.3 citations a year over 3 year(s) since 2025
Impact for its field and year 3 / 6 Cited 4.4× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 7 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record 2 / 3 Washington University in St. Louis: institution h-index 1,962 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 4 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40751419)
Free to read 2 / 2 Free to read
Points 53 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 53 of the 96 points we could judge it on is 55 out of 100.
Total 55 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Schifani, C., Anderson, J. A. E., Nazeri, A., Voineskos, A. N., & the Alzheimer's Disease Neuroimaging Initiative. (2025). In Vivo Cortical Microstructure: Relationships With Tauopathy and Cognitive Impairment in the Elderly. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70167

Vancouver

Schifani C, Anderson JAE, Nazeri A, Voineskos AN, the Alzheimer's Disease Neuroimaging Initiative. In Vivo Cortical Microstructure: Relationships With Tauopathy and Cognitive Impairment in the Elderly. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70167. PMID: 40751419.

BibTeX

@article{schifani2025-40751419,
  author  = {Schifani, Christin and Anderson, John A. E. and Nazeri, Arash and Voineskos, Aristotle N. and {the Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{In Vivo Cortical Microstructure: Relationships With Tauopathy and Cognitive Impairment in the Elderly}},
  journal = {Journal of Neurochemistry},
  year    = {2025},
  doi     = {10.1111/jnc.70167},
  pmid    = {40751419},
  url     = {https://doi.org/10.1111/jnc.70167}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Disease mechanisms

Also tagged “phosphorylated”

732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.

Similar studies

More on Disease mechanisms

See all studies in Disease mechanisms →